Healthcare Professionals With Over 100 Years Of Combined Industry Experience
Co-Founder, President, & CEO
Mr. Clement is a seasoned medical device entrepreneur having brought multiple medical devices to the market over his 30+ year career. The products he has been responsible for bringing to market span Neurosurgery, Interventional Cardiology, Vascular Surgery, Endoscopy, and Radiology. These products include both PMA and 510(k) products. Mr. Clement co-founded Pathway Medical Technologies, Inc. in 1998 and served as CEO until September 2008, as the company developed and brought to market its flagship product, the Jetstream System for treatment of peripheral arterial diseases. He previously was a founding employee and held senior management roles at Heart Technology which was headquartered in the Seattle area. When Boston Scientific acquired Heart Technology, Mr. Clement took on responsibility for the emerging cardiovascular technologies group of the Scimed Division.
Mr. Clement is the immediate past Chairman of the Board of Directors for the Washington Biotechnology & Biomedical Association (WBBA) and serves on two private company boards, one public company board, and several not-for profit boards and Advisory Boards. He was one of the founders of the medtech angel group, WINGS, where he is an active member of the screening committee.
Co-Founder & Chief Medical Officer
Sam Browd, MD, PhD
Dr. Browd is an attending neurosurgeon at Seattle Children’s Hospital where he performs over 160 shunt procedures and over 300 procedures annually. As a surgeon performing a high volume of procedures every year, Dr. Browd is keenly aware of the problems with current technologies marketed for cerebral spinal fluid management. In fact, the inadequacy of existing technology was his motivation to invent improved technology and start Aqueduct. Inventing is not new to Dr. Browd; he has filed and received a patent in a completely different area, a vacuum fixation head bag to immobilize heads – a product that is now being evaluated for commercialization.
Dr. Browd is the lead site investigator for the Hydrocephalus Clinical Research Network (HCRN) at the University of Washington (UW), which has been involved in protocol implementation and data gathering for improvement of hydrocephalus treatment strategies. Dr. Browd’s research efforts outside of the HCRN have focused on image guided neuro-navigation for optimal catheter positioning during shunt placement. He is the co-founder of another company to pursue that technology. Dr. Browd is currently collaborating on various basic science projects to determine the causes of hydrocephalus and shunt malfunction. Dr. Browd is a Professor of Neurological Surgery at the UW School of Medicine where he is the Director of the Hydrocephalus Program.
Co-Founder & Chief Technology Officer
Barry Lutz, PhD
Dr. Lutz has extensive experience developing microfluidic systems for biotechnology applications, and his core expertise in fluid flow is directly applicable to cerebral spinal fluid management. He has been the co-PI with Dr. Browd on several funded grants to develop improved shunt technology, and he was PI on the original LSDF grant to develop the smart external cerebrospinal fluid drain. Dr. Lutz is co-inventor on the Aqueduct technologies developed at the University of Washington under these grants, and he is co-founder of Aqueduct Critical Care, Inc. with Samuel Browd, MD. Dr. Lutz’ other work includes developing fluid-based medical diagnostics, and his projects in that area are also highly translational. Dr. Lutz has received a number of grants designed to move specific point-of-care diagnostics from concept to commercial use.
Dr. Lutz is an Associate Professor and Pilcher Faculty Fellow in the Department of Bioengineering at the University of Washington.
Chief Operating Officer & EVP Finance
Mr. Behlke is an executive corporate officer with 20+ years of experience in finance, operations and general business management primarily in the medical device industry. He has served as a corporate officer and financial executive for both private and public companies with a focus on emerging medical technologies. Over his career, Mr. Behlke has raised more than $145m in private equity financing, primarily venture capital, $25m in debt financing, and $72m in public financing through an initial public offering. He has played a leadership role in the sale of multiple companies with a total exit value of over $700m, including leading the due diligence process and transaction negotiations. Mr. Behlke has also lead the operations function of multiple companies through commercialization and rapid revenue growth, as well as, played a key role in business strategy development.
Sr. VP Business Development
Ms. Amoss has more than 24 years of experience in the healthcare and medical device industry, most recently as a consultant for small to mid-size medical technology companies focusing on strategic marketing and global expansion strategies. Previously, Ms. Amoss served as Senior Vice President of Marketing & Strategic Development for Pathway Medical Technologies, a medical device specializing in endovascular atherectomy which was acquired by MEDRAD/Bayer Healthcare. She has held a variety of leadership positions with small start-ups and mid-sized companies including Spiration, Inc. (acquired by Olympus Medical Systems) and Advanced Cardiovascular Systems, Inc. which eventually became part of Guidant Corporation. Ms. Amoss’ broad range of global management roles in market research, new product introductions, market development, clinical trial management, regulatory, reimbursement and strategic planning within small and large companies makes her particularly valuable to early stage companies endeavoring to take unique technology concepts and transform them into marketable commercial products.
Ms. Amoss holds a Bachelor of Science and a Masters in Business Administration from the University of Washington.
Head of Engineering
Mr. Cran has over 23 years in the medical device industry with experience in designing and commercializing innovative medical products. His career reflects both increasing responsibilities and a breadth of experiences including product design, development phase management, quality systems implementation, and test design & execution in small to large medical device companies. Mr. Cran is named on 15 separate patents. Just prior to joining Aqueduct, Mr. Cran led the product development efforts for Uptake Medical, a start-up specializing in minimally invasive treatment for patients with Chronic Obstructive Pulmonary Disease. Mr. Cran’s work encompassed the very earliest stage of design and development through to the successful commercialization of the Uptake Medical technology. During his career, Mr. Cran has held multiple product and project management roles in emerging technology companies as well as more established corporations.
Mr. Cran’s technical and management expertise, and track record of bringing early product concepts to fully realized and marketable products, has led to the successfull development of the automated external ventricular drain. These skills will continue to be valuable to Aqueduct as the company ultimately commercializes its additional CSF management products.
Mr. Cran received his Bachelors of Science in Aerospace Engineering and Mechanics from the Institute of Technology at the University of Minnesota.